Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents. 2005

Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India.

A new series of N-substituted imide derivatives have been synthesized by treating phthalic anhydride, naphthalic anhydride and their substituted derivatives with 2-hydrazino-1-imidazoline hydrobromide, various para-substituted aryl amines, aminoglutethimide and 2,4-dinitrophenyl hydrazine. Compounds 9, 10, 12, 18, 19, 23, 24 and 34-36 have been selected and screened for antineoplastic activity by National Cancer Institute, Bethesda, USA. Some newer aminoglutethimide derivatives 37-39 have also been prepared in order to study the effect of N-substitution on its pharmacological profile for the treatment of carcinoma. These compounds (37-39) have exhibited weak inhibition of human placental aromatase as compared to aminoglutethimide.

UI MeSH Term Description Entries
D007094 Imides Organic compounds containing two acyl groups bound to NITROGEN. Imide
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047072 Aromatase Inhibitors Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. Aromatase Inhibitor,Inhibitor, Aromatase,Inhibitors, Aromatase

Related Publications

Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
August 2016, Bioorganic & medicinal chemistry letters,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
February 2009, European journal of medicinal chemistry,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
January 2005, Acta poloniae pharmaceutica,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
October 1987, Die Pharmazie,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
April 2007, Archiv der Pharmazie,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
February 1976, Journal of medicinal chemistry,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
June 2014, European journal of medicinal chemistry,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
April 2019, Molecules (Basel, Switzerland),
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
September 2020, Bioorganic chemistry,
Dharam Paul Jindal, and Vikas Bedi, and Birinder Jit, and Nalin Karkra, and Sheetal Guleria, and Ranju Bansal, and Anja Palusczak, and Rolf W Hartmann
May 2013, Archiv der Pharmazie,
Copied contents to your clipboard!